NantHealth, Inc. (NH): Price and Financial Metrics
GET POWR RATINGS... FREE!
NH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for NH is -0.34 -- better than only 5.64% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -1.13 for NANTHEALTH INC; that's greater than it is for just 4.82% of US stocks.
- NANTHEALTH INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 30.06%, greater than the shareholder yield of 93.91% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to NANTHEALTH INC, a group of peers worth examining would be FCEL, ITGR, FARO, AVID, and ICAD.
- Visit NH's SEC page to see the company's official filings. To visit the company's web site, go to nanthealth.com.
NH Valuation Summary
- NH's price/sales ratio is 0.9; this is 65.38% lower than that of the median Technology stock.
- Over the past 77 months, NH's price/sales ratio has gone down 39.8.
Below are key valuation metrics over time for NH.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| NH | 2022-09-16 | 0.9 | -0.3 | -1.0 | -7.3 |
| NH | 2022-09-15 | 1.0 | -0.3 | -1.1 | -7.4 |
| NH | 2022-09-14 | 0.9 | -0.3 | -1.0 | -7.2 |
| NH | 2022-09-13 | 0.8 | -0.3 | -0.9 | -7.2 |
| NH | 2022-09-12 | 0.9 | -0.3 | -1.0 | -7.3 |
| NH | 2022-09-09 | 0.8 | -0.3 | -0.9 | -7.2 |
NH Price Target
For more insight on analysts targets of NH, see our NH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $3.50 | Average Broker Recommendation | 1.25 (Strong Buy) |
NH Stock Price Chart Interactive Chart >
NH Price/Volume Stats
| Current price | $0.25 | 52-week high | $1.91 |
| Prev. close | $0.24 | 52-week low | $0.17 |
| Day low | $0.23 | Volume | 94,800 |
| Day high | $0.26 | Avg. volume | 97,589 |
| 50-day MA | $0.47 | Dividend yield | N/A |
| 200-day MA | $0.67 | Market Cap | 28.46M |
NantHealth, Inc. (NH) Company Bio
NantHealth Inc. operates as a healthcare cloud-based information technology company. The Company offers a clinical platform that provide actionable health information at the point of care for critical illnesses. The company was founded in 2007 and is based in Culver City, California.
Latest NH News From Around the Web
Below are the latest news stories about NANTHEALTH INC that investors may wish to consider to help them evaluate NH as an investment opportunity.
Billionaire's Morrisville firm tries to forestall stock delisting from the NasdaqA prominent billionaire's healthcare technology company in Morrisville is trying to head off its stock being delisted from the Nasdaq. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're breaking down the biggest pre-market stock movers and the news that has them rising and falling for Monday morning! |
NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025MORRISVILLE, N.C., August 24, 2022--NantHealth Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced it has been granted full URAC accreditation for Health Utilization Management for its Eviti Connect platform for another three years. NantHealth’s utilization management procedures have been accredited by URAC since 2010. This latest recognition extends URAC accreditation through September 1, 2025. |
NantHealth, Inc. (NH) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool. NantHealth, Inc. (NASDAQ: NH)Q2 2022 Earnings CallAug 04, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings, and welcome to the NantHealth 2022 second quarter financial results conference call. |
NantHealth Reports 2022 Second Quarter Financial ResultsMORRISVILLE, N.C., August 04, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2022. |
NH Price Returns
| 1-mo | -45.64% |
| 3-mo | -41.37% |
| 6-mo | -66.67% |
| 1-year | -84.66% |
| 3-year | -64.29% |
| 5-year | -94.69% |
| YTD | -76.30% |
| 2021 | -67.34% |
| 2020 | 213.59% |
| 2019 | 90.74% |
| 2018 | -82.30% |
| 2017 | -69.32% |
Continue Researching NH
Want to do more research on NantHealth Inc's stock and its price? Try the links below:NantHealth Inc (NH) Stock Price | Nasdaq
NantHealth Inc (NH) Stock Quote, History and News - Yahoo Finance
NantHealth Inc (NH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...